Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2017Q3 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2017Q2 $ vs. 2017Q2
NEUROCRINE BIOSCIENCES INC 4,791,589 $293,629,000 11.22% +1,214,000 +$129,060,000
AMICUS THERAPEUTICS, INC. 17,888,597 $269,760,000 10.31% +591,925 +$95,582,000
ALNYLAM PHARMACEUTICALS, INC. 1,788,802 $210,167,000 8.03% -43,959 +$63,986,000
Global Blood Therapeutics, Inc. 4,264,066 $132,399,000 5.06% +330,139 +$24,807,000
ZOGENIX, INC. 3,670,357 $128,646,000 4.91% +222,055 +$78,646,000
PUMA BIOTECHNOLOGY, INC. 923,820 $110,627,000 4.23% +190,500 +$46,535,000
LA JOLLA PHARMACEUTICAL CO PAR.0001 2 2,157,011 $75,021,000 2.87% New +$75,021,000
Retrophin, Inc. 2,686,204 $66,859,000 2.55% +13,895 +$15,043,000
AVEXIS INC 671,181 $64,923,000 2.48% +400,000 +$42,643,000
CORIUM INTL INC 5,847,133 $64,786,000 2.48% No Change +$21,166,000
ACCELERON PHARMA INC 1,616,259 $60,319,000 2.30% +905,000 +$38,704,000
Tesaro Inc 388,651 $50,175,000 1.92% +29,100 -$112,000
REGENXBIO Inc. 1,441,186 $47,487,000 1.81% +70,000 +$20,407,000
DOVA PHARMACEUTICALS INC 1,754,015 $42,587,000 1.63% +47,516 +$4,550,000
IOVANCE BIOTHERAPEUTICS, INC. 4,726,114 $36,627,000 1.40% +363,000 +$4,559,000
NxStage Medical, Inc. 1,264,523 $34,901,000 1.33% -291,000 -$4,096,000
ANAPTYSBIO, INC 982,269 $34,330,000 1.31% +30,000 +$11,542,000
Akebia Therapeutics, Inc. 1,630,000 $32,062,000 1.22% +530,000 +$16,254,000
Xencor Inc 1,293,095 $29,638,000 1.13% No Change +$2,341,000
Blueprint Medicines Corp 424,661 $29,586,000 1.13% -20,000 +$7,056,000
INTUITIVE SURGICAL INC 25,195 $26,351,000 1.01% +4,500 +$6,994,000
VBI Vaccines Inc/BC 6,565,843 $25,278,000 0.97% No Change -$3,283,000
CytomX Therapeutics, Inc. 1,390,381 $25,263,000 0.97% No Change +$3,713,000
DBV Technologies S.A. SPONSORED ADR 576,419 $24,463,000 0.93% -15,346 +$3,332,000
HUMANA INC 100,000 $24,363,000 0.93% +21,907 +$5,572,000